Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2021

Loading...
Loading...

 

Upgrades

  • According to Summit Insights Group, the prior rating for ON Semiconductor Corp ON was changed from Hold to Buy. For the fourth quarter, ON Semiconductor had an EPS of $0.35, compared to year-ago quarter EPS of $0.30. The current stock performance of ON Semiconductor shows a 52-week-high of $39.43 and a 52-week-low of $8.17. Moreover, at the end of the last trading period, the closing price was at $36.71.
  • Barclays upgraded the previous rating for Dr Reddy's Laboratories Ltd RDY from Equal-Weight to Overweight. Dr Reddy's Laboratories earned $0.02 in the third quarter, compared to $0.63 in the year-ago quarter. The stock has a 52-week-high of $73.50 and a 52-week-low of $33.33. At the end of the last trading period, Dr Reddy's Laboratories closed at $59.17.
  • For Palo Alto Networks Inc PANW, Credit Suisse upgraded the previous rating of Neutral to Outperform. For the first quarter, Palo Alto Networks had an EPS of $1.62, compared to year-ago quarter EPS of $1.05. The stock has a 52-week-high of $375.00 and a 52-week-low of $125.47. At the end of the last trading period, Palo Alto Networks closed at $361.58.
  • Evercore ISI Group upgraded the previous rating for Tetra Technologies Inc TTI from Underperform to Outperform. In the third quarter, Tetra Technologies showed an EPS of $0.09, compared to $0.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $1.62 and a 52-week-low of $0.22. Tetra Technologies closed at $1.52 at the end of the last trading period.
  • Goldman Sachs upgraded the previous rating for Dell Technologies Inc DELL from Neutral to Buy. Dell Technologies earned $2.03 in the third quarter, compared to $1.75 in the year-ago quarter. The current stock performance of Dell Technologies shows a 52-week-high of $77.72 and a 52-week-low of $25.51. Moreover, at the end of the last trading period, the closing price was at $74.00.
  • According to Credit Suisse, the prior rating for Rio Tinto PLC RIO was changed from Neutral to Outperform. The stock has a 52-week-high of $86.90 and a 52-week-low of $35.35. At the end of the last trading period, Rio Tinto closed at $78.48.

See all analyst ratings upgrades.

 

Downgrades

  • Credit Suisse downgraded the previous rating for BHP Group Ltd BHP from Outperform to Neutral. The current stock performance of BHP Group shows a 52-week-high of $74.41 and a 52-week-low of $29.78. Moreover, at the end of the last trading period, the closing price was at $68.38.
  • For Limelight Networks Inc LLNW, Cowen & Co. downgraded the previous rating of Outperform to Market Perform. Limelight Networks earned $0.01 in the third quarter, compared to $0.01 in the year-ago quarter. At the moment, the stock has a 52-week-high of $8.19 and a 52-week-low of $3.43. Limelight Networks closed at $4.67 at the end of the last trading period.
  • Compass Point downgraded the previous rating for Hilltop Holdings Inc HTH from Buy to Neutral. For the fourth quarter, Hilltop Holdings had an EPS of $1.30, compared to year-ago quarter EPS of $0.54. The current stock performance of Hilltop Holdings shows a 52-week-high of $33.69 and a 52-week-low of $11.05. Moreover, at the end of the last trading period, the closing price was at $30.85.
  • According to Piper Sandler, the prior rating for argenx SE ARGX was changed from Overweight to Neutral. For the third quarter, argenx had an EPS of $3.96, compared to year-ago quarter EPS of $0.72. The current stock performance of argenx shows a 52-week-high of $321.66 and a 52-week-low of $103.75. Moreover, at the end of the last trading period, the closing price was at $317.40.

See all analyst ratings downgrades.

 

Initiations

  • Stephens & Co. initiated coverage on Zix Corp ZIXI with an Overweight rating. The price target for Zix is set to $11.00. In the third quarter, Zix showed an EPS of $0.17, compared to $0.13 from the year-ago quarter. The current stock performance of Zix shows a 52-week-high of $9.46 and a 52-week-low of $2.84. Moreover, at the end of the last trading period, the closing price was at $8.32.
  • MKM Partners initiated coverage on Poshmark Inc POSH with a Buy rating. The price target for Poshmark is set to $88.00. The stock has a 52-week-high of $104.98 and a 52-week-low of $67.18. At the end of the last trading period, Poshmark closed at $73.00.
  • Guggenheim initiated coverage on Phathom Pharmaceuticals Inc PHAT with a Buy rating. The price target for Phathom Pharmaceuticals is set to $60.00. For the third quarter, Phathom Pharmaceuticals had an EPS of $1.02, compared to year-ago quarter EPS of $1.07. The stock has a 52-week-high of $64.54 and a 52-week-low of $22.06. At the end of the last trading period, Phathom Pharmaceuticals closed at $38.49.
  • Wells Fargo initiated coverage on Gracell Biotechnologies Inc GRCL with an Overweight rating. At the moment, the stock has a 52-week-high of $28.88 and a 52-week-low of $20.12. Gracell Biotechnologies closed at $21.81 at the end of the last trading period.
  • Morgan Stanley initiated coverage on Stride Inc LRN with a Equal-Weight rating. The price target for Stride is set to $27.00. The stock has a 52-week-high of $52.84 and a 52-week-low of $15.06. At the end of the last trading period, Stride closed at $27.20.
  • Jefferies initiated coverage on Gracell Biotechnologies Inc GRCL with a Buy rating. The price target for Gracell Biotechnologies is set to $30.00. At the moment, the stock has a 52-week-high of $28.88 and a 52-week-low of $20.12. Gracell Biotechnologies closed at $21.81 at the end of the last trading period.
  • Morgan Stanley initiated coverage on Chart Industries Inc GTLS with an Overweight rating. The price target for Chart Industries is set to $135.00. Chart Industries earned $0.80 in the third quarter, compared to $0.77 in the year-ago quarter. At the moment, the stock has a 52-week-high of $143.56 and a 52-week-low of $15.00. Chart Industries closed at $127.54 at the end of the last trading period.
  • With an Outperform rating, SVB Leerink initiated coverage on Cullinan Management Inc CGEM. The price target seems to have been set at $52.00 for Cullinan Management. The stock has a 52-week-high of $43.00 and a 52-week-low of $27.01. At the end of the last trading period, Cullinan Management closed at $33.77.
  • With a Buy rating, Citigroup initiated coverage on Clover Health Investments Corp CLOV. The price target seems to have been set at $19.00 for Clover Health Investments. The stock has a 52-week-high of $17.24 and a 52-week-low of $13.10. At the end of the last trading period, Clover Health Investments closed at $13.81.
  • Stephens & Co. initiated coverage on Mimecast Ltd MIME with an Overweight rating. The price target for Mimecast is set to $57.00. In the second quarter, Mimecast showed an EPS of $0.32, compared to $0.13 from the year-ago quarter. The current stock performance of Mimecast shows a 52-week-high of $59.48 and a 52-week-low of $25.14. Moreover, at the end of the last trading period, the closing price was at $44.45.
  • Stephens & Co. initiated coverage on Proofpoint Inc PFPT with an Overweight rating. The price target for Proofpoint is set to $165.00. For the third quarter, Proofpoint had an EPS of $0.59, compared to year-ago quarter EPS of $0.49. The current stock performance of Proofpoint shows a 52-week-high of $140.91 and a 52-week-low of $83.81. Moreover, at the end of the last trading period, the closing price was at $130.62.
  • Stephens & Co. initiated coverage on Ping Identity Holding Corp PING with an Overweight rating. The price target for Ping Identity Holding is set to $40.00. For the third quarter, Ping Identity Holding had an EPS of $0.11, compared to year-ago quarter EPS of $0.13. The current stock performance of Ping Identity Holding shows a 52-week-high of $37.80 and a 52-week-low of $12.02. Moreover, at the end of the last trading period, the closing price was at $30.83.
  • With an Outperform rating, Raymond James initiated coverage on Neurocrine Biosciences Inc NBIX. The price target seems to have been set at $163.00 for Neurocrine Biosciences. Neurocrine Biosciences earned $0.97 in the third quarter, compared to $0.90 in the year-ago quarter. The stock has a 52-week-high of $136.26 and a 52-week-low of $72.14. At the end of the last trading period, Neurocrine Biosciences closed at $106.02.
  • With an Overweight rating, Piper Sandler initiated coverage on Gracell Biotechnologies Inc GRCL. The price target seems to have been set at $40.00 for Gracell Biotechnologies. At the moment, the stock has a 52-week-high of $28.88 and a 52-week-low of $20.12. Gracell Biotechnologies closed at $21.81 at the end of the last trading period.
  • Piper Sandler initiated coverage on Surgalign Holdings Inc SRGA with an Overweight rating. The price target for Surgalign Holdings is set to $4.00. For the third quarter, Surgalign Holdings had an EPS of $0.11, compared to year-ago quarter EPS of $0.01. At the moment, the stock has a 52-week-high of $3.15 and a 52-week-low of $1.49. Surgalign Holdings closed at $1.70 at the end of the last trading period.
  • With an Overweight rating, Piper Sandler initiated coverage on Nevro Corp NVRO. The price target seems to have been set at $190.00 for Nevro. Nevro earned $0.29 in the third quarter, compared to $0.58 in the year-ago quarter. The current stock performance of Nevro shows a 52-week-high of $188.14 and a 52-week-low of $65.05. Moreover, at the end of the last trading period, the closing price was at $163.86.

See all analyst ratings initiations.

Loading...
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...